SciELO - Scientific Electronic Library Online

 
vol.15 issue1Numerical analysis on stresses and contact areas in a TKR Scorpio II® of Stryker®. Basis to design of customized TKR in accordance to Mexican PhenotypeDifferential molecular diagnosis Colletotrichum gloeosporioides and Fusarium oxysporum in yam (Dioscorea sp.). author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Colombiana de Biotecnología

Print version ISSN 0123-3475

Abstract

MORANTES, Sandra Johanna; PERDOMO, Sandra; CARRILLO, Edward Fabián  and  ARISTIZABAL, Fabio. Characterization of chemosensitivity profile gene amplification status of a panel of lung cancer cell lines. Rev. colomb. biotecnol [online]. 2013, vol.15, n.1, pp.42-51. ISSN 0123-3475.

In this paper, we show results of anticancer drug sensitivity assays and studies of gen amplification performed for a panel of lung cancer cell lines. For the chemosensitivity assays the cells were treated for 48 h with different concentrations of taxol, cisplatin, doxorubicin and 5-fluorouracil. The cytotoxic effect of each drug was determined using the resazurin reduction assay and reported in terms of inhibitory concentration 50 (IC50). For the analysis of gene amplification we used TaqMan® probes designed against AKT2, PIK3CA, ERBB2, EGFR, REL and MYC family members. Copy number for each gene was calculated using the delta-delta-CT method, employing ACTB as reference gen and MRC-5 cell line as control sample. In the chemosensitivity assays, we observed a clear decrease in cell viability in the cells treated with taxol, cisplatin and doxorubicin but not in the cells treated with 5-fluorouracil. IC50 values ranging between 0,38± 0,03 µM and 111,3 ±3,58 µM, being the taxol and doxorubicin the most potent drugs. NCI-H292 cell line was the most sensitivity and LSPG8G cell line was the most resistant. Interestingly, NCI-H292 cells did not show increase in the copy numbers for the gene evaluated, in contrast, we observed changes in the gene dosage for cMYC, MYCN, MYCL and AKT2 in LSPG8G cells. These results suggest that gene amplification could contribute to drug resistance in lung cancer cell lines; however, more studies are needed to confirm this hypothesis.

Keywords : lung cancer; in vitro cytotoxicity; gene dosage; NCI-H292; LSPG8G.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )